Overview

Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS)

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the effectiveness of 2 IBS treatment strategies: - Strategy A = MeteoSpasmyl®, on-demand therapy - Strategy B = standard of care chosen by the physician
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Laboratoires Mayoly Spindler
Treatments:
Alverine
Mebeverine
Parasympatholytics
Criteria
Inclusion Criteria:

- male or female ambulatory patients, aged >= 18 years

- with IBS as defined by Rome III criteria for more than 1 year and less than 10 years

- with a IBS-SSS between 175 and 400

Exclusion Criteria:

- Acute diarrhea, bowel disorders due to an underlying cause

- Patient treated with MeteoSpasmyl® within the past 6 months

- Recent history of gastro intestinal surgery